A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS

NCT00002257 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Cytomegalovirus Retinitis
HIV Infections

Interventions

DRUG: Ganciclovir

Sponsor

Hoffmann-La Roche